Health
Novel nanobody combinations protect cells from SARS-CoV-2 in vitro – Drug Target Review
By combining nanobodies targeting different regions of the SARS-CoV-2 Spike protein, researchers were able to protect cells from infection.
Posted: 14 January 2021 | Hannah Balfour (Drug Target Review) | No comments yet
By combining nanobodies targeting different regions of the SARS-CoV-2 Spike protein, researchers were able to protect cells from infection.
Researchers have developed combined nanobodies which can neutralise SARS-CoV-2, even if it mutates. According to the team, the nanobodies could be developed a drug treatment for use in those critically ill with COVID-19, the disease caused by SARS-CoV-2, or people that may not be…
-
General23 hours agoCampers evacuated, residents on alert as Moreton Island bushfire intensifies
-
General21 hours agoHundreds attend justice march for Kaiden Morgan-Johnston in Morwell
-
Noosa News24 hours agoATO investigator found to have lied in fraud case
-
Noosa News21 hours agoAlleged Gold Coast conman exposed: elderly woman’s life savings vanish in shocking scam